Navigation Links
Omnicell Announces First Quarter 2008 Results
Date:4/21/2008

> Advance payments from customers 583 156

Accrued liabilities 11,552 12,877

Deferred service revenue 12,540 11,263

Deferred gross profit 19,397 14,565

Obligation resulting from sale of

receivables 410 538

Total current liabilities 65,015 57,821

Long-term deferred service revenue 17,019 15,726

Other long-term liabilities 189 237

Total liabilities 82,223 73,784

Stockholders' equity 225,497 254,639

Total liabilities and

stockholders' equity $307,720 $328,423

Omnicell, Inc.

Reconciliation of GAAP to Non-GAAP

(in thousands, except per share data, unaudited)

Three months ended

March 31, 2008 December 31, 2007

Earnings Earnings

per per

Net share- Net share-

income diluted income diluted

GAAP $3,733 $0.10 $14,297 $0.39

Non-GAAP Adjustments:

SFAS No. 123R adjustment (a)

Gross Margin 510 469

Operating Expenses 2,557 2,680

Income tax adjustment (b) (7,217)

3,067 0.09 (4,
'/>"/>

SOURCE Omnicell, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Omnicell Schedules First Quarter 2008 Earnings Call
2. Omnicell Announces Completion of Its Common Stock Repurchase Plan
3. Omnicell Announces Common Stock Repurchase Program; Reaffirms Earnings Forecast
4. Hospital Environments Increase Staff Efficiency and Patient Safety With Omnicell OptiFlex(TM) SS 9.0
5. Omnicell Schedules Fourth Quarter Earnings Call
6. Omnicell Debuts Industrys First Total Automated Patient-Specific Management Solution
7. Omnicell Announces Agreement to Acquire Rioux Vision, Inc.
8. Omnicell to Present at Piper Jaffray 19th Annual Health Care Conference
9. Hendricks Regional Health Increases Patient Safety and Pharmacy Efficiency With Omnicell WorkflowRx 5.0
10. Omnicell Reports Strong Q3 Revenue and Profit Growth
11. Grant Regional Health Center Increases Patient Safety and Pharmacy Efficiency with Omnicell Medication Use Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
(Date:12/4/2009)Rockville, MD "Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision , may lie in
Breaking Medicine News(10 mins):Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Are angry women more like men? 2
...r the first time, a new study has looked into how ...derstand and retell a script-based story. , When...ing to a restaurant, we remember the kinds of acti...are listening to a story that takes place at a res...
...sudden loss of T cells -- white blood cells crucia...he onset of AIDS, according to a study published i...ology by a team of researchers at Tulane National ... current thinking regarding AIDS, namely that a su...
...NGTON, Sept. 21 Business Roundtable and,the Ameri...h the,Roundtable,s Partnership for Disaster Respon...the business community to contribute its vast,reso...ement is timed with National Preparedness Month, a...
...ned National Security Facility to Offer EHR-Enhanc...tration/Billing for 8,500 Employees ...ghlights Growing Trend of Computer-Enhanced Onsite...linical software and,information solutions that ph...
...IEGO, Sept. 21 ChemDiv, Inc. (San Diego) announce...tute (CDRI, Moscow) is,undertaking a partnership w...the Russian Academy of Medical Sciences, the US De...state cancer,(PRC). The partnership will operate u...
...WOOD, Colo., Sept. 21 Baxa Corporation, a leading...elivery in hospital,pharmacies, announces the addi.... These agreements -- with Magallan Pharma Trading... South,America and the Caribbean. "Global markets...
Other Medicine News:Health News:Progression of SIV infection in monkeys raises 2Health News:Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nation's Preparedness for Disasters 2Health News:Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nation's Preparedness for Disasters 3Health News:Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nation's Preparedness for Disasters 4Health News:Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center 2Health News:Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center 3Health News:Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center 4Health News:Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership 2Health News:Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership 3Health News:Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic 2
(Date:12/3/2009)MADISON, N.J., Dec. 3 A genetic variation that may indicate a patient,s risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is
(Date:12/3/2009)SAN DIEGO, Dec. 3 BioMed Realty Trust, Inc. (NYSE: BMR ) announced today that it has entered into a new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) for approximately 131,000 square
(Date:12/3/2009)HOERSHOLM, Denmark and SAN DIEGO, California, December 3 , - SPC3649 Successfully Inhibits miR-122, a microRNA Important for,Hepatitis C Viral Replication, Thereby Significantly Reducing Hepatiti
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 1Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 2Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 3Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 4Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 5Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 6Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 7Stent Studies Tied to Rapid Changes in Use 52992 1Stent Studies Tied to Rapid Changes in Use 52992 2DURECT to Present at the BMO Capital Markets Healthcare Conference 52990 1DURECT to Present at the BMO Capital Markets Healthcare Conference 52990 2
...s,Inc. (Amex: IMM ) is pleased to announce today ...h as a strategic advisor. General Clark will,provi...pany develops its,drug programs targeting various ...tion and treatment. General Clark is one of the c...ers and a respected international voice in public ...
...ry biliary cirrhosis patient,has the biomarker of ...nic,researchers have found that first-degree relat...s with primary biliary cirrhosis (PBC) are,more li... blood. Armed with,this new information, physician...f PBC patients with a simple blood test, enabling ...
Other Medicine Technology:General Wesley Clark Joins Immtech as Consulting Strategic Advisor 2General Wesley Clark Joins Immtech as Consulting Strategic Advisor 3New Research May Lead to Earlier Diagnosis and Treatment of Primary Biliary Cirrhosis in Families 2
DNA Engine Thermal Cycler Chassis, w/96-well block & motorized lid
DNA Engine Thermal Cycler Chassis
MBS Satellite Thermal Cycler 0.5ml
MBS Satellite Thermal Cycler 0.2ml
Medicine Products: